Literature DB >> 19818367

Trans-presentation: a novel mechanism regulating IL-15 delivery and responses.

Spencer W Stonier1, Kimberly S Schluns.   

Abstract

Interleukin (IL)-15 is a cytokine that acts on a wide range of cell types but is most crucial for the development, homeostasis, and function of a specific group of immune cells that includes CD8 T cells, NK cells, NKT cells, and CD8 alpha alpha intraepithelial lymphocytes. IL-15 signals are transmitted through the IL-2/15R beta and common gamma (gamma C) chains; however, it is the delivery of IL-15 to these signaling components that is quite unique. As opposed to other cytokines that are secreted, IL-15 primarily exists bound to the high affinity IL-15R alpha. When IL-15/IL-15R alpha complexes are shuttled to the cell surface, they can stimulate opposing cells through the beta/gamma C receptor complex. This novel mechanism of IL-15 delivery has been called trans-presentation. This review discusses how the theory of trans-presentation came to be, evidence that it is the major mechanism of action, the current understanding of the cell types thought to mediate trans-presentation, and possible alternatives for IL-15 delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818367      PMCID: PMC2808451          DOI: 10.1016/j.imlet.2009.09.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  77 in total

1.  Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist.

Authors:  Erwan Mortier; Jérôme Bernard; Ariane Plet; Yannick Jacques
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

2.  IL-15 is an essential mediator of peripheral NK-cell homeostasis.

Authors:  Thomas Ranson; Christian A J Vosshenrich; Erwan Corcuff; Odile Richard; Werner Müller; James P Di Santo
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

3.  Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells.

Authors:  Kimberly S Schluns; Kimberly D Klonowski; Leo Lefrançois
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

4.  An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex.

Authors:  T Takeshita; K Ohtani; H Asao; S Kumaki; M Nakamura; K Sugamura
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

5.  Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression.

Authors:  Kimberly S Schluns; Elizabeth C Nowak; Arturo Cabrera-Hernandez; Lynn Puddington; Leo Lefrançois; Hector L Aguila
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-01       Impact factor: 11.205

6.  Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.

Authors:  Rima Koka; Patrick Burkett; Marcia Chien; Sophia Chai; David L Boone; Averil Ma
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

7.  Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection.

Authors:  Masahisa Jinushi; Tetsuo Takehara; Tomohide Tatsumi; Tatsuya Kanto; Veronika Groh; Thomas Spies; Takahiro Suzuki; Takuya Miyagi; Norio Hayashi
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

8.  Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction.

Authors:  Toshihiko Kawamura; Rima Koka; Averil Ma; Vinay Kumar
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

9.  Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17).

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Andreas Ludwig; Stefan Rose-John; Paul Saftig; Ernest C Borden; Silvia Bulfone-Paus
Journal:  J Biol Chem       Date:  2004-06-23       Impact factor: 5.157

10.  Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.

Authors:  Patrick R Burkett; Rima Koka; Marcia Chien; Sophia Chai; David L Boone; Averil Ma
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

View more
  83 in total

1.  Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model.

Authors:  Ping Yu; Jason C Steel; Meili Zhang; John C Morris; Thomas A Waldmann
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

2.  Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

Authors:  Bree Foley; Sarah Cooley; Michael R Verneris; Michelle Pitt; Julie Curtsinger; Xianghua Luo; Sandra Lopez-Vergès; Lewis L Lanier; Daniel Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

3.  IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood.

Authors:  Michael C Sneller; William C Kopp; Kory J Engelke; Jason L Yovandich; Stephen P Creekmore; Thomas A Waldmann; H Clifford Lane
Journal:  Blood       Date:  2011-11-08       Impact factor: 22.113

Review 4.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

5.  Interleukin-15 and its receptor (IL-15Rα) serve as new therapeutic implications for Behçet's disease.

Authors:  Yong He; Cheng Huang; Bao-Ming Wu; Jun Li
Journal:  Rheumatol Int       Date:  2013-09-18       Impact factor: 2.631

6.  Epithelial IL-15 Is a Critical Regulator of γδ Intraepithelial Lymphocyte Motility within the Intestinal Mucosa.

Authors:  Madeleine D Hu; Alexander D Ethridge; Rebecca Lipstein; Sushil Kumar; Yitang Wang; Bana Jabri; Jerrold R Turner; Karen L Edelblum
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

Review 7.  Design and development of therapies using chimeric antigen receptor-expressing T cells.

Authors:  Gianpietro Dotti; Stephen Gottschalk; Barbara Savoldo; Malcolm K Brenner
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Authors:  Clémentine Perrier; Ingrid Arijs; Dominiek Staelens; Christine Breynaert; Isabelle Cleynen; Kris Covens; Marc Ferrante; Gert Van Assche; Séverine Vermeire; Gert de Hertogh; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

9.  Adhesion- and Degranulation-Promoting Adapter Protein Promotes CD8 T Cell Differentiation and Resident Memory Formation and Function during an Acute Infection.

Authors:  Jessica K Fiege; Lalit K Beura; Brandon J Burbach; Yoji Shimizu
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

10.  IL-15 trans-presentation regulates homeostasis of CD4(+) T lymphocytes.

Authors:  Xi-Lin Chen; Diwakar Bobbala; Yuneivy Cepero Donates; Marian Mayhue; Subburaj Ilangumaran; Sheela Ramanathan
Journal:  Cell Mol Immunol       Date:  2014-03-24       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.